The Group working on Biosafety focusses on GMOs, biosecurity, regulation, capacity enhancement, technical assistance, products of modern biotechnology and training.
The ICGEB represents a scientific reference point for Parties that have ratified the Convention on Biological Diversity and, in particular, the Cartagena Protocol on Biosafety concerning the transboundary movement of genetically modified organisms (GMOs).
The role of ICGEB’s Biosafety Group is to assist countries in their capacity to identify, regulate, manage and monitor products derived from modern biotechnology within their own jurisdiction. This is achieved through a comprehensive approach involving the provision of technical assistance and advisory services to effect capacity enhancement.
The activities of the Biosafety Group are financially sustained through significant contributions from eminent international donors and philanthropic foundations. Activities range from drafting legislation, regulations and guidance documents to organising in-country mentored fora in which novice GMO regulators are trained in model approaches and tools in the regulation of GMOs, and are assisted in tailoring these to national circumstances.
Biosafety Capacity Building in sub-Saharan Africa
Assisting the Caribbean Regional Biosafety project
GRACE: GMO Risk Assessment and Communication of Evidence
Italian BCH: Biosafety Clearing House
A compilation of scientific studies on areas of major interest for biosafety and risk assessment prepared by internationally-recognised scientists
A portfolio of curriculum-based modules encompassing the biosafety of genetically modified organisms and related matters in biosecurity, public health, natural resource management, biocontrol and bioremediation.
Ndolo D, Wach M, Rüdelsheim P & Craig W, 2018. A Curriculum-Based Approach to Teaching Biosafety Through eLearning. Frontiers in Bioengineering and Biotechnology, 6: 42-49
Rosado A, Craig W, 2017. Biosafety regulatory systems overseeing the use of genetically modified organisms in the Latin America and Caribbean region. AgBioForum, 20(2): 120-132
Craig W, Ndolo DO, Tepfer M, 2017. A Strategy for Integrating Science into Regulatory Decision-Making for GMOs. Chapter 3. In “Genetically Modified Organisms in Developing Countries. Risk Analysis and Governance“. AA Adenle, EJ Morris & DJ Murphy (eds). Cambridge University Press, UK. pp 26-38
Racovita M, Obonyo DN, Craig W, Ripandelli D, 2015. What are the non-food impacts of GM crop cultivation on farmers’ health? Environmental Evidence 4:17
Obonyo DN, Racovita M, Ripandelli D, Craig W, 2014.Biosafety issues in food and agricultural systems in Africa
Racovita M, Obonyo DN, Craig W, Ripandelli D, 2014. What are the non-food impacts of GM crop cultivation on farmers’ health? A systematic review protocol. Environmental Evidence 3(1)
For more information: